US2005250204A1PendingUtilityA1
Methods and apparatus for separation of particles
Est. expiryDec 5, 2021(expired)· nominal 20-yr term from priority
Inventors:Glen Delbert Antwiler
A61M 1/0218A61M 2202/0439B01D 21/262B04B 5/0442B01D 2221/10G01N 33/491A61M 1/3696B04B 2005/0471A61M 1/3693A61M 1/3692
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a method for separating particles. The invention has particular advantages in connection with separating and purifying progenitor cells or stem cells obtained from bone marrow. The method comprises removing a desired volume of stem cell staring product from a donor/patient and eluting off a first contaminating cell type in a fluid chamber to create an enriched stem cell product.
Claims
exact text as granted — not AI-modified1 . A method of enriching stem cells comprising the steps of:
removing a desired volume of stem cell starting product from a donor/patient to obtain a stem cell starting product; loading the stem cell starting product into a fluid chamber; flowing a low density fluid into the loaded stem cell starting product in the fluid chamber; centrifuging the fluid chamber; and eluting off a first contaminating cell type from the stem cell starting product in the fluid chamber to create an enriched stem cell product; and collecting the enriched stem cell product.
2 . The method of claim 1 further comprising a debulking step to remove a first contaminating cell type from the stem cell starting product.
3 . The method of claim 2 wherein the debulking step occurs before the eluting step.
4 . The method of claim 1 further comprising concentrating the enriched stem cell product.
5 . The method of claim 1 wherein the stem cell starting product further comprises bone marrow.
6 . The method of claim 1 wherein the stem cell product further comprises peripheral blood.
7 . The method of claim 1 wherein the stem cell product further comprises umbilical cord blood.
8 . The method of claim 5 wherein the step of removing bone marrow further comprises filtering the bone marrow.
9 . The method of claim 8 wherein the filtering step occurs before the loading step.
10 . The method of claim 1 further comprising eluting off a second contaminating cell type from the starting product in the fluid chamber.
11 . The method of claim 1 further comprising eluting off a third contaminating cell type from the starting product in the fluid chamber.
12 . The method of claim 1 further comprising eluting off a fourth contaminating cell type from the starting product in the fluid chamber.
13 . The method of claim 1 comprising repeating the loading, flowing, centrifuging, eluting and collecting steps as many times as necessary to obtain the desired number of enriched stem cells.
14 . The method of claim 2 comprising repeating the loading, flowing, debulking, and centrifuging steps as many times as necessary to remove undesired cells before the eluting step.
15 . The method of claim 4 further comprising repeating the concentrating step as many times as necessary to obtain the desired number of enriched, concentrated stem cells.
16 . The method of claim 1 wherein the flowing step comprises flowing a low density fluid into the fluid chamber at a flow rate of around 37 mL/min at a volume of around 500 mL.
17 . The method of claim 2 wherein the first contaminating cell type is red blood cells.
18 . The method of claim 10 wherein the second contaminating cell type is platelets.
19 . The method of claim 11 wherein the third contaminating cell type is T-cells.
20 . The method of claim 12 wherein the fourth contaminating cell type is B-cells.
21 . A method of treating a damaged organ with stem cells collected from bone marrow comprising the steps of:
removing a desired volume of bone marrow from a donor/patient to obtain a bone marrow starting product; loading the bone marrow starting product into a fluid chamber; flowing a low density fluid into the loaded bone marrow starting product in the fluid chamber; centrifuging the fluid chamber; debulking a first contaminating cell type from the bone marrow starting product in the fluid chamber; eluting off a second contaminating cell type from the bone marrow starting product in the fluid chamber to create an enriched stem cell product; concentrating the enriched stem cell product to obtain a concentrated, enriched stem cell product; and injecting the concentrated enriched stem cell product into the damaged organ.
22 . The method of claim 21 further comprising determining the amount of stem cells needed to treat the damaged organ.
23 . The method of claim 21 wherein the step of injecting further comprises injecting the concentrated enriched sample into cardiac tissue.
24 . The method of claim 21 wherein the step of injecting further comprises injecting the concentrated enriched stem cell product intravenously.
25 . The method of claim 21 wherein the step of injecting further comprises injecting the concentrated enriched stem cell product intramuscularly.
26 . The method of claim 21 wherein the step of injecting further comprises injecting the concentrated enriched stem cell product both intravenously and intramuscularly.
27 . The method of claim 21 wherein the step of injecting further comprises injecting the concentrated enriched stem cell product in multiple injections.
28 . The method of claim 21 wherein the step of injecting further comprises injecting the concentrated enriched stem cell product in a single injection.Join the waitlist — get patent alerts
Track US2005250204A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.